-Products-Jinan Liangfu Jinghe Pharmaceutical Technology Co., Ltd.

Products

API & Intermediates
Cell Signaling Pathway Inhibitors
Small Molecule Compounds
Impurity Reference Standards
Others

	Address: 2766 Yingxiu Road, Jinan High-Tech Zone, China
	Tel: Sales: +86-531-88811783 Evaluation:+86-531-88806178 R&D: +86-531-88813691 Office: +86-531-88817621
	Fax: +86-531-88817925
	Zip Code: 250101
	Email: Trade Department: sales@trio-pharmatech.com G&D&E: register@trio-pharmatech.com yzxpj@trio-pharmatech.com R&D center:: newdrugs@trio-pharmatech.com

Now Position:Home > Products >

Product No.	CAS No.	Name	Category
TP1038A	211555-04-3	WHI-P154	Inhibitors of EGFR pathways
TP1038C	656247-17-5	Intedanib	Anti-cancer API
TP1039A	1214265-56-1	WZ3146	Inhibitors of EGFR pathways
TP1039M	343247-69-8	1-(4-chloro-3-(trifluoromethyl)phenyl)urea	Intermediates of API
TP1040A	1213269-23-8	WZ4002	Inhibitors of EGFR pathways
TP1040DZ01	137863-20-8	Valsartan impurity C	Valsartan Series
TP1040DZ02	952652-79-8	Valsartan impurity B	Valsartan Series
TP1040DZ03	676129-92-3	Valsartan impurity E; (S)-3-Methyl-2-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]aminobutanoic acid	Valsartan Series
TP1040M	320-51-4	5-Amino-2-chlorobenzotrifluoride	Intermediates of API
TP1041A	1214265-57-2	WZ8040	Inhibitors of EGFR pathways
TP1041DZ01	121-30-2	Hydrochlorothiazide Impurity B	Hydrochlorothiazide Series
TP1041DZ02	402824-96-8	Hydrochlorothiazide Impurity C	Hydrochlorothiazide Series
TP1041M	284462-37-9	4-(4-Aminophenoxy)-N-methylpicolinamide	Intermediates of API
TP1042A	651031-01-5	XL647	Inhibitors of EGFR pathways
TP1042M	220000-87-3	N-Methyl-4-chloropyridine-2-carboxamide	Intermediates of API
TP1043A	850879-09-3	Amuvatinib; MP-470	Inhibitors of PDGFR pathways
TP1043M	24484-93-3	Methyl 4-chloropicolinate	Intermediates of API
TP1044M	649735-46-6	Brivanib	Intermediates of API
TP1045A	319460-85-0	Axitinib; AG-013736	Inhibitors of PDGFR pathways
TP1045A	319460-85-0	Axitinib; AG-013736	Inhibitors of VEGFR pathways

Total 1369 item(s)　Total 69 Page(s)　Now page:5　 First page Pre Next Last page Jump to page